Table 3.
Clinical features of metastatic cancer by metastatic site
| Feature | Metastatic sitea | |||||
|---|---|---|---|---|---|---|
| Bone metastases | Liver metastases | Lung metastases | ||||
| OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | |
| Low back pain | 2.6 (1.0 to 6.7) | 0.045 | – | – | – | – |
| Vomiting | – | – | 4.7 (1.3 to 17.5) | 0.021 | – | - |
| Pleurisy/effusion | – | – | – | – | 10.5 (1.0 to 118.7) | 0.050 |
| Abnormal liver function test | 4.6 (1.6 to 11.7) | 0.004 | 2.9 (1.1 to 7.9) | 0.041 | 5.1 (1.1 to 24.2) | 0.043 |
a
For these analyses, patients with metastases in multiple sites were studied in each relevant group (bone metastases, n = 75; liver metastases, n = 55; lung metastases, n = 45). OR = odds ratio.